HMGB1 augments cognitive impairment in sepsis‐associated encephalopathy by binding to MD‐2 and promoting NLRP3‐induced neuroinflammation

Abstract

Background Sepsis‐associated encephalopathy (SAE) always manifests with severe inflammatory symptoms and cognitive impairment. High mobility group box 1 (HMGB1) is a pro‐inflammatory cytokine. In this study we investigated the role of HMGB1 in SAE. Methods An SAE mouse model was established through cecal ligation and puncture surgery and then injected with adenovirus short hairpin RNA (Ad‐sh)‐HMGB1 or Ad‐sh‐myeloid differentiation protein (MD‐2). The cognitive impairment and pathological injury in mice of different groups were evaluated using the Morris water maze experiment, Y‐maze test, tail suspension test, fear conditioning test, and haematoxylin‐eosin staining. The expressions of HMGB1 (fully reduced and disulfide (ds)HMGB1), MD‐2, and NLRP3 in SAE mice were determined. Then, levels of inflammatory cytokines were measured. The binding relation between HMGB1 and MD‐2 was predicted and certified. Additionally, MD‐2 was downregulated to verify the role of the binding of HMGB1 and MD‐2 in neuroinflammation and cognitive impairment in SAE. Results Expressions of HMGB1, MD‐2, NLRP3, and inflammatory cytokines were enhanced in the SAE mouse model, which were in parallel with impaired cognitive function. HMGB1 silencing resulted in downregulated NLRP3 expression and alleviated neuroinflammation and cognitive impairment in SAE mice. Mechanically, dsHMGB1 bound to MD‐2 to activate NLRP3, thereby exacerbating neuroinflammation and cognitive impairment in SAE mice. The limited binding of HMGB1 and MD‐2 downregulated NLRP3 expression to alleviate neuroinflammation and cognitive impairment in SAE mice. Conclusion HMGB1 was overexpressed in SAE, and dsHMGB1 bound to MD‐2 to activate NLRP3 inflammasome, inducing neuroinflammation and cognitive impairment in SAE.

HSF1 Alleviates Brain Injury by Inhibiting NLRP3-Induced Pyroptosis in a Sepsis Model

“…The brain could be impaired by increasing inflammatory cytokines in sepsis. Unfortunately, there is no effective way to prevent or even treat this grievous disease, and the pathogenesis of brain injury in sepsis remains to be clarified [59,60]. The occurrence of brain injury in sepsis is closely related to inflammation, and inhibiting the inflammatory factors' expression in brain tissues could alleviate sepsis encephalopathy [13].…”

A comprehensive insight into the molecular and cellular mechanisms of action of resveratrol on complications of sepsis a systematic review

“…The high mobility group of box 1 (HMGB1), a nuclear and secreted protein, plays a pivotal role in amplifying the onset of inflammatory cascades by binding immunostimulatory agents namely IL‐1a, LPS, etc (Xiong et al, 2022). Several mechanism pathways are proposed regarding the stimulatory effects of the HMGB1 on the production of different cytokines (Xiong et al, 2022). Also, resveratrol could prohibit the activation of the HMGB1 by acting in several ways (Xu et al, 2014).…”

Neuroinflammation Following Traumatic Brain Injury: Take It Seriously or Not

“…HMGB1, a cytokine released by glia and neurons upon inflammasome activation and that activates Toll 4 and the receptor for advanced glycation end products (RAGE). The HMGB1-RAGE interaction that mediated HMGB1 endocytosis followed by direct NF-κB activation has been widely studied, while the HMGB1 interacts with MD-2 to trigger TLR-4, and downstream signaling was relatively rare ( 36 , 44 ). Despite the fact that the HMGB1 blockade can dampen neuroinflammation post-TBI, the effects of HMGB1 antagonism on neurogenesis remain been elucidated.…”